Drug Discovery World

DECEMBER 29, 2022

Recombinant DNA technology and its impact on modern drug discovery . Exploring the microbiome: how it is shaping preclinical research . What does gene-based medicine have to offer? . . Catch up on the Sitting Down With podcast episodes released in 2022: . Narrated Podcasts.

Recombinant DNA Technology 52

Recombinant DNA Technology Genome Genomics DNA 52

Cloudbyz

MARCH 6, 2024

Unlike traditional small molecule drugs, which are chemically synthesized, biologics are produced through complex biotechnological processes, often involving recombinant DNA technology. Understanding Biologics: Biologics are a class of therapeutic agents derived from living organisms, such as cells, tissues, or proteins.

Gene 83

Gene Immune Response Manufacturing Gene Therapy 83

Pharmaceutical Technology

FEBRUARY 15, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Gene splicing using nucleases. Nucleases are enzymes that hydrolytically cleave the phosphodiester backbone of DNA.

Gene Splicing 130

Gene Splicing Gene Recombinant DNA Technology DNA 130

Advarra

JUNE 13, 2024

Recombinant DNA technologies and genetically modified biological agents are being adapted for a wide scope of therapeutic applications, and their use is becoming increasingly common in clinical trials. These IPs pose the lowest risk amongst all recombinant IPs.

Genetic Engineering 52

Genetic Engineering Clinical Trials Clinical Trials Engineer 52

Drug Discovery World

MAY 4, 2023

Recombinant DNA technology and improved protein purification techniques further contributed to our understanding and explorations of drug targets. Essentially, a biological network is a connected graph of nodes that could represent diseases, genes, proteins, atoms, organs, microorganisms, drugs or ligands.

Medicine 52

Medicine Protein Drugs Bioassay 52